Karo Bio cuts losses as R&D progresses
Swedish drug discovery company Karo Bio has trimmed its losses down
to SEK18.1 million in the second quarter of 2003 from SEK79.7
million a year earlier.
EU states taken to ECoJ over biotech
European Commission refers eight EU member states to the European
Court of Justice over their alleged failure to implement legal
protection of biotech inventions.
Amersham extends CyDye fluor range
Amersham Biosciences has added to its range of CyDye mono-reactive
fluor dyes with two products used for labelling proteins or
antibodies in protein array experiments.
4SC and Esteve extend CNS project
A pilot project aimed at identifying new drug candidates for
central nervous system disorders, initiated by Germany's 4SC and
Spain's Esteve, has grown into a full-blown collaboration between
Swedish BioTech Forum planned for November
The Karolinska Institute, together with the Swedish academy of
pharmaceutical sciences, is organising BioTech Forum 2003, to take
place from 26 to 28 November in Stockholm, Sweden.
Expressionist paints picture of cancer genetics
Genedata's Expressionist software is to be used in a cancer
research effort in Singapore aimed at developing clinical
diagnostics and identifying novel drug targets.
SARS yields secrets… and drug targets
A team of scientists studying severe acute respiratory syndrome
has, for the first time, described how the coronavirus (SARS CoV)
manufactures several of the materials required for viral
IBC event promises low down on drug design
IBC is holding its 3rd international conference on Small Molecule
& Protein Structure-Based Drug Discovery by Design on 8-10
October 2003 in San Diego.
Roche escapes Igen damages, but loses ECL rights
A US appeals court has reversed an earlier decision to make
Switzerland's Roche pay almost $500 million in damages to Igen in a
dispute over a technology used in clinical diagnostics and
Symphogen strengthens Ab patent position
Danish biotech company Symphogen has obtained a European patent on
its Symphage technology for the development of antibody-based
drugs. Clinical trials of the product candidate are due to start in
Applied Bio launches rat gene expression assays
A series of pre-formulated rat gene expression assays developed by
Applied Biosystems could provide a short cut to testing
toxicological responses to chemical compounds.
GSK settles Augmentin dispute with Novartis
Novartis has agreed to pay GlaxoSmithKline a royalty on sales of a
generic version of GSK's antibiotic Augmentin
(amoxicillin/clavulanate) sold in the USA as AmoxC.
Crestor clears FDA panel
Crestor (rosuvastatin), the 'superstatin' developed by AstraZeneca,
has been recommended for approval by a US Food and Drug
Administration advisory panel.
Biovation to improve Centocor proteins
Biovation has signed up Centocor as a new client for its technology
to reduce the immunogenicity of protein-based therapeutics.
New approach to molecular modelling
A technique known as electron momentum spectroscopy may provide a
means of improving rational drug design by allowing direct
measurement of the wavefunction of large molecules.